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Abstract Engineering biosynthetic pathways in heterolo-
gous microbial host organisms offers an elegant approach
to pathway elucidation via the incorporation of putative
biosynthetic enzymes and characterization of resulting
novel metabolites. Our previous work in Escherichia coli
demonstrated the feasibility of a facile modular approach to
engineering the production of labdane-related diterpene (20
carbon) natural products. However, yield was limited
(<0.1 mg/L), presumably due to reliance on endogenous
production of the isoprenoid precursors dimethylallyl
diphosphate and isopentenyl diphosphate. Here, we report
incorporation of either a heterologous mevalonate pathway
(MEV) or enhancement of the endogenous methyl eryth-
ritol phosphate pathway (MEP) with our modular metabolic
engineering system. With MEP pathway enhancement, it
was found that pyruvate supplementation of rich media and
simultaneous overexpression of three genes (idi, dxs, and
dxr) resulted in the greatest increase in diterpene yield,
indicating distributed metabolic control within this path-
way. Incorporation of a heterologous MEV pathway in
bioreactor grown cultures resulted in significantly higher
yields than MEP pathway enhancement. We have estab-
lished suitable growth conditions for diterpene production
levels ranging from 10 to >100 mg/L of E. coli culture.
These amounts are sufficient for nuclear magnetic reso-
nance analyses, enabling characterization of enzymatic
products and hence, pathway elucidation. Furthermore, these
results represent an up to >1,000-fold improvement in
diterpene production from our facile, modular platform, with
MEP pathway enhancement offering a cost effective alter-
native with reasonable yield. Finally, we reiterate here that
this modular approach is expandable and should be easily
adaptable to the production of any terpenoid natural product.
Keywords Terpenoid . Natural products biosynthesis .
Metabolic engineering . Isoprenoid
Introduction
Metabolic engineering to introduce heterologous biosyn-
thetic pathways into microbial host organisms offers an
elegant method for not only the production of “natural”
products, but also for pathway elucidation and biochemical
enzymatic investigation. In vivo production of appropriate
precursors as substrates for putative, recombinantly coex-
pressed biosynthetic enzymes, coupled with characteriza-
tion of the resulting product, provides a means for
investigating enzymatic specificity and hence, their role in
metabolic pathways. Emerging genomic sequences from a
variety of organisms highlights the need to functionally
investigate the encoded multifaceted metabolism. Central to
any metabolic engineering effort is the ability to redirect
appreciable carbon flux from central metabolism toward
desired heterologous end products, which assumes partic-
ular importance when the production of novel metabolites
necessitates their structural analysis.
Among the most biochemically interesting biosynthetic
pathways are those producing natural products, which present
a rich source of chemical diversity. However, these com-
pounds are often found in low abundance, are difficult to
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isolate, and are refractory to chemical synthesis, thus making
them a challenge for investigation (Clardy and Walsh 2004).
Among the natural products, over 100,000 low molecular
weight compounds known as secondary metabolites have
been identified. Although, by definition, these compounds
are not required for normal growth and development, they do
perform a variety of biological functions, including antimi-
crobial defense and growth regulation, providing the
selective force for such biochemical evolution (Firn and
Jones 2003). In addition, about half of all prescribed
therapeutic drugs in use today, particularly the invaluable
antibiotics, have their origins in natural products, either directly
or as semisynthetic derivatives (Newman and Cragg 2007).
The largest family of natural products is the terpenoids
or isoprenoids (>40,000), comprised of various numbers of
five carbon isoprene units, which are derived from
isopentenyl diphosphate (IPP) and dimethylallyl diphos-
phate (DMAPP) precursors (McGarvey and Croteau 1995).
In nature, there are two routes leading to IPP and DMAPP,
the methyl erythritol phosphate (MEP) and mevalonic acid
(MEV) pathways (Scheme 1). While the MEV pathway,
found primarily in eukaryotes, begins with acetyl-CoA, the
prokaryotic and plant plastid MEP pathway is initiated by
condensation of glyceraldehyde-3-phosphate and pyruvate
(Rohmer 2008). The resulting IPP and in the case of the
MEP pathway, its allylic isomer DMAPP, can be inter-
converted to balance their use in production of longer chain
isoprenoid precursors. These are produced by prenyltrans-
ferases via the addition of IPP to allylic diphosphate
precursors, beginning with DMAPP, to sequentially pro-
duce geranyl diphosphate, farnesyl diphosphate, and ger-
anylgeranyl diphosphate (GGPP), which are the immediate
precursors of the C10 mono-, C15 sesqui-, and C20
diterpenoids, respectively.
We have previously reported development of a modular
metabolic engineering system for facile investigation of
diterpene synthases (Cyr et al. 2007). In particular,
coexpression of a GGPP synthase with various combina-
tions of the class II cyclases and class I synthases
responsible for the two-step enzymatic conversion of GGPP
into multicyclic labdane-related diterpenes, although this
system can be used with any diterpene synthase (and with
minor modification, any terpene synthase). However, the
resulting diterpene yields were relatively low (<100 µg/L of
recombinant bacterial culture), hindering use of the system
for characterization of novel enzymatic activities. These
initial investigations relied upon the endogenous pools of
IPP and DMAPP. Previous work, generally targeted at
production of individual or small groups of terpenoids,
often carotenoids (C40 tetraterpenoids whose phytoene
precursor is formed by condensation of two GGPP), has
demonstrated that engineering the MEVand MEP pathways
can dramatically increase isoprenoid yield (Das et al. 2007).
Here, we report that such precursor pathway engineering
also dramatically increases yield (up to >1,000-fold) in the
context of our modular system, which provides a means for
its use in de novo investigation of novel enzymatic activity
and hence, corresponding metabolic pathways. Our inves-
tigations further highlight a number of practical issues that
can be important considerations in the application of
isoprenoid precursor pathway engineering.
Results
Initial optimization of growth conditions
To minimize the number of manipulations necessary to
measure diterpene production, the bifunctional diterpene
cyclase abietadiene synthase from Abies grandis (AgAS),
which has both class II and I activities, was coexpressed
with a GGPP synthase, also from A. grandis (AgGGPS),
using our previously described pGGAS dual expression
vector (Cyr et al. 2007). Transformation of this vector is
sufficient to endow the resulting recombinant Escherichia
coli with the ability to produce the expected abietadiene
(Scheme 2). Production of this diterpene was analyzed
under a variety of growth conditions, particularly variation
in liquid growth media and length of postinduction culture
fermentation. With this minimally engineered strain
(pGGAS only), it was found that rich TB media ultimately
enabled higher cell densities and diterpene yield compared
to NZY media (Supplemental Fig. 1). This increase in yield
was particularly evident with longer fermentations in TB
media, which exhibited continued accumulation of abieta-
diene up to the point at which cell densities started to
decrease (Fig. 1), as measured by absorbance at 600 nm
(A600). Culture viability and hence, diterpene yield, was
extended by growing the cells in liquid media alone, rather
than the previously described 2% (weight per volume)
hydrophobic bead containing mixed phase conditions
(Supplemental Fig. 1). Perhaps due to its ability to
sequester diterpene extracellularly, rather than the presumed
accumulation in cell membranes, mixed phase cultures did
result in more efficient production of diterpene compared to
liquid media cultures, as evidenced by greater yields
normalized for cell densities at the peak of cell growth;
however, the usage of two-phase cultures resulted in poorer
cell growth and lower net diterpene production. The results
of these various preliminary experiments suggested a
correlation between diterpene yield and cell density. No
loss of diterpene, either from exogenously added controls
or metabolically engineered production, was observed even
after prolonged growths of up to a week in duration,
suggesting that at the optimal 16 °C production growth
temperature loss to volatilization or bacterial degradation is
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minimal (Supplemental Fig. 2). Through these various
improvements in growth conditions, abietadiene yield was
increased to over 2 mg/L bacterial culture, representing a
significant improvement in net yield from the previously
reported ≤0.1 mg/L (Cyr et al. 2007).
Engineering the endogenous MEP pathway
Previously reported engineering of the endogenous MEP
isoprenoid precursor pathway indicates that terpenoid yield
OPP
H
OPP
H
GGPP abietadieneCPP
Scheme 2 Conversion of GGPP to abietadiene, via CPP, catalyzed by
the bifunctional diterpene synthase AgAS
Fig. 1 Cell culture density (triangles) and production of abietadiene
in milligram per liter (circles) over time from endogenous pools of IPP
and DMAPP. E. coli was transformed with pGGAS plasmid and
cultures grown in shake flasks with TB media. Error bars depict
standard deviation of duplicate trials
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Scheme 1 a MEP pathway found in plant plastids and prokaryotes.
DXS: DXP synthase, DXR: DXP reductase, IspD: ME-4-phosphate
cytidyltransferase, IspE: 4-(cyt-5′-diphospho)-ME kinase, IspF: ME-
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in E. coli can be increased by overexpression of three of the
relevant enzymatic genes; 1-deoxy-D-xylulose-5-phosphate
synthase (dxs), 1-deoxy-D-xylulose-5-phosphate reductase
(dxr), and/or isopentenyl diphosphate isomerase (idi) (Das
et al. 2007). However, these studies differed in which genes
were found to be beneficial and overexpressed, at most,
only two of these three. Thus, the ability of overexpression
of these MEP pathway genes to increase diterpene
production was explored here by the creation of compatible
expression vectors carrying either single genes (pDXS,
pDXR, pIDI), two gene combinations (pSR, pIS, pIR), or
all three genes (pIRS). Each of these was cotransformed
with pGGAS and abietadiene yield from the resulting
recombinant E. coli determined in duplicate (Table 1).
Overexpression of idi, either alone or in combination with
dxs and/or dxr, consistently increased diterpene yield. By
contrast, overexpression of dxr, dxs, or both actually
decreased diterpene yield. In addition, while coexpression
of idi with either dxs or dxr increased diterpene yield
relative to overexpression of dxs or dxr alone, the resulting
level remained below that of the control (pGGAS only)
strain. Nevertheless, overexpression of dxs, dxr, and idi
together increased diterpene yield, even beyond that
observed with idi alone, although this was limited to an
approximate threefold increase relative to the control. To
summarize, in three independent trial series, the order of
increasing effectiveness in diterpene production for the
MEP pathway combinations was consistently found to
follow the corresponding trend:
dxr < dxs  idiþ dxr < dxsþ dxr < idiþ dxs  idi
< idiþ dxsþ dxr
Addition of a heterologous MEV pathway
Dramatic increases in bacterial isoprenoid yield resulting
from the introduction of a heterologous MEV pathway from
Sacchromyces cereviseae have been reported by the
Keasling group (Martin et al. 2003). This was accomplished
by providing the enzymatic genes necessary for the
production of mevalonate from acetyl-CoA (in a synthetic
operon encoding the “top half” of the MEV pathway) with
the pMevT vector, while those for the production of IPP
from mevalonate (in a synthetic operon encoding the
“bottom half” of the MEV pathway), along with idi, were
provided by the pMBI vector. Notably, feeding mevalonate
to recombinant strains containing pMBI only was sufficient
to essentially replicate the increased isoprenoid yield
obtained by addition of the full MEV pathway (i.e., use
of both pMevT and pMBI). By design, our modular
metabolic engineering system is compatible with pMBI,
which has been previously used to increase diterpene yield
(Morrone et al. 2008). However, due to the associated
Table 1 Abietadiene yield upon isoprenoid pathway engineeringa
Pathway Plasmid(s)b Pathway genes Yield (mg/L) Yield (mg/L/A600)
– – – 2.6 ± 0.3 0.22 ± 0.04
MEP pIDI idi 3.9 ± 0.4 0.35 ± 0.02
MEP pDXS dxs 1.3 ± 0.3 0.14 ± 0.03
MEP pDXR dxr 0.9 ± 0.1 0.08 ± 0.01
MEP pIS dxs, idi 2.7 ± 0.5 0.22 ± 0.06
MEP pSR dxs, dxr 2.5 ± 1.3 0.30 ± 0.1
MEP pIR idi, dxr 2.7 ± 0.1 0.24 ± 0.01
MEP pIRS idi, dxr, dxs 7.3 ± 0.7 0.89 ± 0.09
MEV pMBI (0 mM)d ERG12, ERG8, MVD1, idi 1.8 ± 0.2 0.20 ± 0.02
MEV pMBI (10 mM)d ERG12, ERG8, MVD1, idi 38.4 ± 2.4 3.4 ± 0.2
MEV pMBI (20 mM)d ERG12, ERG8, MVD1, idi 51.5 ± 5.3 5.8 ± 0.5
MEV pMBI (40 mM)d ERG12, ERG8, MVD1, idi 0.5 ± 0.2 0.7 ± 0.3
MEV pMBID (20 mM)c,d ERG12, ERG8, MVD1, idi 0.3 ± 0.1 0.1 ± 0.03
MEV pMevT+pMBI ERG12, ERG8, MVD1, idi atoB, tHMGR, HMGS 12.0 ± 3.0 0.8 ± 0.2
MEV pMTH+pMBI ERG12, ERG8, MVD1, idi atoB, tHMGR×2, HMGS 22.3 1.5
a All cultures for comparison of MEP pathway engineering or MEV pathway engineering were grown in parallel, with all data representing the
average ± standard deviation from duplicate cultures
b All strains in Table 1 contained the pGGAS plasmid necessary for abietadiene production unless otherwise specified
c This strain carried pDEST14-AgAS in place of pGGAS
dAmount of supplemented mevalonolactone
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expense of mevalonate feeding, incorporation of the full
MEV pathway also was pursued.
In an attempt to reduce the number of plasmids
necessary for diterpene production, AgGGPS was trans-
ferred from pGGAS to the synthetic operon in pMBI,
producing pMBID. Unfortunately, coexpression of pMBID
with AgAS alone (from a separate pET-based expression
vector rather than pGGAS) resulted in the production of
very little abietadiene. This may be due to the noticeably
poor growth of the corresponding recombinant strain, for
which cell densities in shake flask cultures were A600 ≤4.0.
The Keasling group has previously reported that incor-
poration of an additional copy of a truncated form of 3-
hydroxy-3-methylglutaryl-CoA reductase (hmgr) to the
“bottom half” of the MEV pathway further increases
isoprenoid yield (Pitera et al. 2007). Further, pMevT is
not compatible with our modular metabolic engineering
system. In particular, while pMevT is compatible with
pGGAS, it is incompatible with the pDEST vector series
typically used for expression of the class I diterpene
synthases catalyzing the secondary rearrangement and/or
cyclization reaction in labdane-related diterpene biosynthe-
sis (Cyr et al. 2007). Hence, the synthetic operon from
pMevT was moved into a dual expression vector that also
encoded an additional copy of the truncated hmgr gene
under control of a separate promoter, creating pMTH.
Coexpression of pMBI with pGGAS, along with feeding
mevalonate to 20 mM, increased the yield of abietadiene.
Mevalonate feeding experiments determined that amounts
of 10 mM were most efficiently converted to diterpene;
while 20 mM provided the highest net yield, it was not as
efficiently converted to diterpene as 10 mM concentrations
(Table 1). Additionally, it was found that amounts of
40 mM mevalonate appear toxic to E. coli, as evidenced by
a complete inhibition of cell growth after mevalonate
addition at induction and minimal diterpene yield. These
results are similar to those reported earlier (Martin et al.
2003). Addition of the full MEV pathway using pMevT
resulted in high abietadiene yield, which could be further
increased by incorporation of the extra copy of truncated
hmgr via use of pMTH instead of pMevT (Table 1).
Reoptimization of growth conditions
Given the significant increases seen with basic optimization
of the growth conditions for the minimally engineered
pGGAS contain strain of E. coli, more investigations were
undertaken with the further engineered MEP and MEV
isoprenoid precursor pathway strains. Initially, a variety of
media conditions were tested to determine a suitable media
recipe for the metabolic engineering of E. coli or diterpene
production. Media recipes for NZY, buffered NZY (NZY
B), buffered NZY+glycerol (NZY BG), TB, and buffered
2xNZY + 2% glycerol (FL) were tested. The richer media
of TB and FL resulted in increased culture density and
diterpene production (Fig. 2a). However, it was consistently
found that glycerol significantly retarded initial growth. As
a result, glycerol supplementation was initiated at induc-
tion. Additionally, the optimal glycerol concentration was
determined to be 2% based on diterpene production and
culture density in a series of biofermentations wherein
glycerol content was varied within TB media (Fig. 2b).
Growths relying on lactose autoinduction failed to produce
as much diterpene product as did IPTG induction. Further-
more, the use of baffled flasks greatly enhanced culture
density, presumably because of increased gas exchange.
Baffled flasks shaken at 200 rpm with optimal media
conditions routinely allowed culture densities with A600 >20.
As suggested earlier, the increased cell density was
correlated with an increase in diterpene production
(Fig. 3) and coupled with the limitations of mevalonalac-
tone, presumably due to toxicity, high density titers are
desired. Finally, to supplement MEP pathway utilization,
addition of pyruvate as a precursor was tested. Addition of
50 mM pyruvate to MEP pathway enhanced (pIRS)
cultures resulted in an approximately twofold increase in
diterpene production to a level of ∼14 mg/L (Fig. 4). The
combination of the optimization of media, culturing
conditions, and precursor feeding for abietadiene biofer-
mentation production with the previously determined high
yielding vector combinations from the MEP and MEV
pathways given in Table 1 are depicted in Fig. 5.
Combining MEP and MEV pathway engineering
The increases in diterpene production observed through
metabolic engineering by using the MEP and heterologous
MEV pathway modules prompted us to test combinations
using both pathways and incorporating multiple copies of
the class II and class I modules. These combinations and
multiplicities are listed in Table 2. Essentially, none of the
attempts to incorporate both pathways or multiple copies of
various biosynthetic enzymes resulted in higher yields
compared to the heterologous MEV pathway alone. Growth
was generally poor in the cultures requiring four modules
and four markers. When yields were normalized for cell
density, the combination of the MEP and MEV pathway
with the minimally engineered strain (pMBI+pIRS+
pGGAS) did provide amounts of abietadiene similar to
the MEV strain just using pMBI (5.8 vs 5.6 mg/L/A600);
however, the net yield of the combination strain was
significantly lower. These results are consistent with the
suggestion that only catalytic amounts of the enzymes are
required, and rather, it is flux that is desired for high yield.
Central to this appears to be the ability of the expressing
culture as a whole to either have sufficient uptake of
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exogenous precursors or to perhaps produce a large
precursor pool if using an endogenous supply; in either
case, it suggests an advantage in net yield from high density
cultures.
Bioreactor yields
Previous reports have suggested that the use of bioreactors
enables higher cell density and greater isoprenoid yields
(Newman et al. 2006). Thus, the ability of bioreactor grown
cultures to further increase diterpene production in the
context of our modular metabolic engineering system in E.
coli was investigated. Previous work with our bioreactor
(New Brunswick BioFlo110) demonstrated the effective-
ness of pulsed feeding of glycerol and mevalonate for
pMBI to 4% and 20 mM, respectively (Morrone et al.
2008). Briefly, every 12 h after induction up to 48 h, a
solution of glycerol and mevalonate was injected, with the
sum of the injections totaling up to the targeted 4% and
20 mM concentrations. In bioreactor growths under optimal
media and growth conditions, we were able to obtain cell
densities of A600 ≈15, with yields of ∼30 mg/L and ∼200 mg/
L abietadiene for strains carrying pGGAS and pMBI, with
either pMTH or mevalonate feeding, respectively (Fig. 6).
For comparison, the use of a bioreactor to increase yield
from a strain with an engineered endogenous MEP pathway
(i.e., the recombinant strain carrying the optimal pIRS+
pGGAS) also was investigated. This led to a yield of
∼20 mg/L of abietadiene. Notably, while the diterpene
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Fig. 3 Correlation of abietadiene production with cell density. Baffled
flasks were utilized to grow cultures in TB media to final cell density
averages of 15.2, 20.1, and 22.6. Extraction and analysis was
performed 48 h after induction, at cell density peak. All data is from
cultures grown in parallel, with error bars depicting the standard
deviation of duplicate cultures
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Fig. 2 Reoptimization of
growth and media conditions
tested using the minimally
engineered MEV strain (pMBI+
pGGAS) for abietadiene pro-
duction in E. coli, with both net
and normalized yields depicted.
Mevalonate (20 mM) was added
to shake flask cultures grown for
72 h in duplicate. a The results
of abietadiene yield for the
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b The results of abietadiene
yield for the various amounts of
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to TB media. All data is from
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yields are less for the MEP pathway compared to the MEV,
it is important to distinguish that there is no need for either
costly mevalonate supplementation or for the utilization of
two plasmids (pIRS versus pMBI and pMTH). In addition,
while use of a bioreactor did increase yield (quite
dramatically in the case of pMBI coexpression with
mevalonate supplementation), the downside is the expense
of such instrumentation and their complexity relative to
shake flask growths. To determine the yield from a
relatively simple and cost effective approach, a recombinant
strain carrying pIRS+pGGAS was grown in 1 L of FL
media in a 2.8-L baffled flask, with 50 mM pyruvate
supplementation, resulting in ∼16 mg of abietadiene, an
amount that is sufficient for chemical characterization by
nuclear magnetic resonance (NMR), as well as further
biochemical studies (e.g., precursor/substrate feeding
experiments).
Extension to other labdane-related diterpenes
Among the labdane-related diterpenes, there are three
commonly found stereoisomers. These are designated by
comparison to the A/B ring configuration found in
abietadiene, which is then termed normal, with ent- and
syn- stereoisomers also commonly found. We previously
demonstrated use of our modular system for facile
production of labdane-related diterpenes of all three
configurations (Cyr et al. 2007). This was accomplished
via dual expression vectors expressing AgGGPS and a
stereospecific class II diterpene cyclase, forming a small
series of pGGxC vectors wherein pGGnC, pGGeC, and
pGGsC enable production of normal, ent-, or syn- copalyl
diphosphate (CPP), respectively. These CPP intermediates,
in turn, can then be reacted upon by class I stereospecific
labdane-related diterpene synthases. To demonstrate that
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Fig. 5 Optimal cell growth and production of abietadiene in
metabolically engineered E. coli as a function of time. Biofermenta-
tion with pMBI+pGGAS supplemented with 20 mM mevalonolactone
(triangles), pIRS+pGGAS (circles), and pMTH+pMBI+pGGAS
(squares). Baffled shake flasks were used along with TB media
optimized from previous experimental findings. Trials were performed
in duplicate. a Cell growth over time. b Yield over time. c Normalized
net yields. All data is from cultures grown in parallel, with error bars
depicting the standard deviation of duplicate cultures
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the optimization described above for production of abieta-
diene is more broadly applicable, we tested pGGeC and
pGGsC, with coexpression of a relevant class I labdane-
related diterpene synthase (i.e., pumpkin (Cucurbita max-
ima) ent-kaurene synthase (CmKS) or a rice (Oryzae sativa)
syn-stemodene synthase (OsKSL11), respectively
(Scheme 3)), under optimized conditions (i.e., in TB media
with pMBI and pulsed feeding of 20 mM mevalonate).
Yields in both cases were significantly higher than that
previously reported (Cyr et al. 2007), even in shake flask
cultures (Fig. 7), with further significant increases seen in
bioreactor fermentations, much as observed for abietadiene
production.
However, with both pGGeC and pGGsC, the net
diterpene yields were lower than those observed for
pGGAS. While the syn-CPP synthase in pGGsC is the
only such enzyme known (Xu et al. 2004), there are many
ent-CPP synthases known beyond that from Arabidopsis
thaliana (AtCPS) utilized in the original version of pGGeC.
Thus, we constructed variants of pGGeC using different
ent-CPP synthases, specifically that from corn (Zea maize,
An2 (Harris et al. 2005)), from rice (Oryza sativa, OsCPS2
(Prisic et al. 2004)), and the bacteria Bradyrhizobium
japonicum (BjCPS; Morrone et al. 2009). With the
exception of that constructed with BjCPS, the resulting
variously derived pGGeC vectors allowed for sufficient
culture growth with cell densities of similar values to those
observed with abietadiene production (Supplemental
Fig. 3). Notably, the version of pGGeC carrying An2
improved ent-kaurene yield threefold relative to the original
AtCPS-derived construct (Fig. 7) and was found to offer
higher yields with several different ent-kaurene synthases,
indicating that the production of ent-CPP had been a
limiting step (Supplemental Fig. 4).
Given the role for Mg2+ as an enzymatic cofactor for
both classes of diterpene synthases, we investigated the
ability of exogenously added Mg2+ to further increase yield
(Fig. 8). While this did not improve yields of abietadiene,
the addition of low millimolar concentrations (∼5 mM) of
Mg2+ to FL media does increase diterpene yield with
pGGsC and pGGeC(An2), although not pGGeC(AtCPS).
Discussion
The potential of metabolic engineering and synthetic
biology is still being explored. For example, innovative
work by the Keasling group has recently demonstrated that
it is possible to metabolically engineer E. coli to produce
large quantities of artemisinic acid, a usable precursor for
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Table 2 Abietadiene yield with combined isoprenoid pathway engineeringa
Pathway(s) Plasmid(s) Class II/class I synthases Yield (mg/L) Yield (mg/L/A600)
MEV pMBI, pGGnC, pDEST-AgAS normal, 2× class II, 1× class I 40.9 ± 5.2 3.6 ± 0.6
MEV pMBI, pGGAS, pDEST-AgAS normal, 1× class II, 2× class I 24.0 ± 6.1 2.1 ± 0.5
MEP+MEV pIRS, pMBI, pGGAS normal, 1× class II, 1× class I 11.4 ± 6.4 5.6 ± 2.3
MEP+MEV pIRS, pMBI, pGGnC, pDEST- AgAS normal, 2× class II, 1× class I 3.4 ± 0.2 2.3 ± 0.3
MEP+MEV pIRS, pMBI, pGGAS, pDEST- AgAS:D404A normal, 1× class II, 2× class I 2.3 ± 1.1 1.6 ± 0.5
MEP+MEV pIRS, pMBI, pGGAS, pDEST- AgAS normal, 2× class II, 2× class I 2.9 ± 0.6 1.8 ± 0.4
a All cultures in Table 2 were supplemented with 20 mM mevalonolactone; MEP containing cultures were also supplemented with 50 mM
pyruvate. All data is from cultures grown in parallel, with the average ± standard deviation from duplicate cultures presented
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semisynthetic production of the antimalarial sesquiterpe-
noid natural product and medically relevant drug artemisi-
nin (Chang et al. 2007). This, and indeed most, published/
reported work in the area of metabolic engineering has
focused on the production of single or small groups of
related, generally known compounds through manipulation
of the corresponding specific biosynthetic pathway. How-
ever, this limits the utility of the developed system for
investigation of novel metabolism. We wish to utilize
metabolic engineering instead for biosynthetic pathway
elucidation and enzymatic investigation via facile incorpo-
ration of putative biosynthetic enzymes and characterization
of the resulting novel metabolites.
Our interest centers on the large superfamily of labdane-
related diterpenoids, which is comprised of almost 7,000
known natural products. Many of these are exclusively
found in plants, whose large and complex genomes
preclude ready identification of the corresponding enzy-
matic genes by physical proximity or on the basis of
homology (particularly in the case of multigenic families).
To provide a platform for facile investigation of novel
enzymatic activity, we have developed a modular system
for metabolically engineering E. coli to produce labdane-
related diterpenes (Cyr et al. 2007). This provides an
elegant approach to elucidation of diterpenoid biosynthetic
pathways and corresponding enzymatic investigation and
one that is amendable, with slight adaptation, to the study
of any type of terpenoid metabolism. However, in order to
realize this potential, it must be possible to readily produce
the multimilligram quantities of resulting metabolite(s)
needed for structural analysis (i.e., by NMR).
Initial work on this system demonstrated the ability of E.
coli to produce desired diterpenes, albeit in small quantities
of <100 µg/l of culture, presumably due to the limited
endogenous isoprenoid precursor pools (Cyr et al. 2007).
Here, we have set out to shift carbon flux from E. coli
central metabolism for milligram production of diterpenes
in liter scale culture growths. Two basic approaches were
investigated, either supplementation of the endogenous
MEP isoprenoid precursor pathway via overexpression of
key enzymatic genes or addition of a heterologous MEV
isoprenoid precursor pathway (this latter either in whole or,
with supplementation, in part). The ability of these alterna-
tive approaches to improve diterpene production was
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Fig. 7 Comparison of diterpene yield from various CPS. Production
of syn and ent diterpenes by metabolically engineered E. coli using the
various class II cyclases depicted with minimal MEV pathway (i.e.,
pMBI + 20 mM mevalonate feeding). Biofermentation was performed
in shake flask cultures with TB media and harvested 72 h postinduction
in parallel duplicate trials. a Net values of diterpene produced. b Values
of diterpene produced normalized for cell density. Error bars depict
standard deviation (a) and propagated standard deviation, without
covariance (b). All data is from cultures grown in parallel, with error
bars depicting the standard deviation of duplicate cultures
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Scheme 3 Conversion of GGPP to various labdane-related diter-
penes. GGPP is converted to ent or syn-CPP by class II CPS enzymes
and subsequently to hydrocarbon olefins by stereospecific class I
labdane-related diterpene synthases, resulting in ent-kaurene and syn-
stemodene, respectively
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assessed by analysis of their impact on abietadiene yield
from cells coexpressing GGPP and abietadiene synthases.
Engineering MEP pathway enzymatic gene overexpres-
sion was found to increase abietadiene production. Inter-
estingly, while only idi improved yield on its own, further
improvement was evident upon overexpression of idi with
both dxs and dxr, although these actually decreased yield on
their own and when paired with each other or idi (Table 1).
As culture growth was unimpaired by any combination of
MEP enzymes and only abietadiene diterpene product yield
was affected, this suggests flux through the pathway may
be most responsible for the varied outcome arising from
different gene combinations. Further, these results suggest
that the investigated MEP pathway enzymatic genes exert
distributed metabolic control, specifically dxs and dxr.
While the isomerization of DMAPP and IPP mediated by
idi seems to be the initial rate-limiting step, further increases
are dependent on overexpression of both dxs and dxr.
Notably, the production of 1-deoxy-D-xylulose-5-phosphate
(DXP) mediated by dxs is not unique to isoprenoid
precursor production, which is initiated by the ensuing
production of 2-C-methyl-D-erythitol-4-phosphate mediated
by dxr. Thus, our results suggest that increased flux to DXP
(i.e., from dxs overexpression) is shunted to alternative
metabolic fates in the absence of increased dxr activity,
although overexpression of dxr alone also is not sufficient
on its own to compete with the alternative pathways.
Introduction of a heterologous MEV pathway, either in
part (with the appropriate supplementation) or whole,
increased abietadiene yield beyond that observed with
engineering of the endogenous MEP pathway (Table 1).
These increases were particularly significant in bioreactor
grown cultures, where yields >100 mg/L were observed,
representing a >1,000-fold increase over that previously
reported. However, this requires either costly mevalonate
supplementation or the use of two plasmids for introduction
of the whole MEP pathway, which limits the number of
downstream steps that can be incorporated. In addition,
obtaining truly significant increases further required use of
a bioreactor. Nevertheless, baffled shake flask growth
conditions with even the single plasmid associated with
optimal MEP pathway engineering produces >10 mg/L of
diterpene, providing a simple and economical means for
obtaining the multimilligram quantities of novel metabolites
necessary for their structural analysis.
Critically, the improvements reported here have been
directly applied to the further incorporation of additional
enzymatic genes (i.e., pairs of diterpene synthases rather
than the bifunctional AgAS), carried on yet another
plasmid, also with yields exceeding 100 mg/L in bioreactor
fermentations. Thus, it should be possible to use the
developed modular metabolic engineering system, with
the yield improvements reported here, to investigate
multistep biosynthetic pathways. We reiterate here that
these include not only the labdane-related diterpenes that
are the focus of our research, but other diterpenoid natural
products and with slight modification (i.e., replacement of
the GGPP synthase), other types of terpenoids as well.
Materials and methods
General
All molecular biology reactions were performed according
to standard protocols. Polymerase chain reaction (PCR)
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Fig. 8 Effect of Mg2+ on diterpene yield. MEV pathway combina-
tions consisting of pMBI+pGGxC+pDEST class I were assayed for
diterpene yield under varying amounts of Mg2+ in FL media shake
cultures with 20 mM mevalonate added and 72 h of cultivation. The
various class II cyclases used in the pGGxC modules are indicated on
the x-axis and grouped. Mg2+ concentrations (0 to 50 mM) are
indicated above bars. Abietadiene synthase, kaurene synthase, and
stemodene synthase were utilized in the pDEST class I modules with
the appropriate pGGxC base vector. a Net diterpene yield. b
Normalized yield. All data is from cultures grown in parallel, with
error bars depicting the standard deviation of duplicate cultures
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was performed using Accuprime Pfx (Invitrogen), liga-
tions were performed using T4 ligase (New England
Biolabs), restriction endonuclease cleavage by New
England Biolabs protocols, DNA preparations and gel
extractions by Quiagen kits, and LR recombinations and
entry cloning was performed by standard Gateway
technology protocols (Invitrogen). Plasmid pGGAS was
a pACYCDuet vector housing the GGPP synthase and
abietadiene synthase from A. grandis in the first and second
multiple cloning sites (MCS), respectively, as previously
described (Cyr et al. 2007). All vectors and genes were
verified by sequencing.
Design of vectors
The DUET family of vectors (Novagen) contain two MCS,
each with its own T7 promoter and ribosome-binding site
optimally positioned before the inserts. Incorporation of
DESTination cassettes (Invitrogen) allows essentially any
plasmid to be converted into a ligation-free module vector
to allow for facile transfer of any gene into expression
plasmids using the simple Gateway LR technology (Invi-
trogen). For our modular approach, a DESTination cassette
containing attR1 recombination site, ccdB lethality selec-
tion gene, chloramphenical resistance gene, and attR2
recombination site, which allows for easier ligase-free att
site recombination with removal of cassette selection genes,
was inserted just downstream of the T7 promoter in the first
multiple cloning site (MCS 1) in DUET vectors (Table 2).
Construction of DEST cassette containing vectors was
carried out via standard PCR, restriction enzyme, and
ligation protocols, using NcoI and NotI sites. This DEST
cassette allows quick transfer of any gene from a pENTR-
containing entry vector (Gateway) into the DESTination-
converted expression vector. As the use of DEST cassettes
necessitates a long sequence (>50 bp) prior to the start
codon, we utilize pENTR/SD entry clones, which have a
Shine–Delgarno site optimally positioned before the start
codon. All DEST containing Duet vectors were made in the
same fashion (Table 3).
Vectors used for the MEV pathway were a kind gift from
Prof. Jay Keasling (Martin et al. 2003). In their pMevT, the
first three genes of the yeast MEV pathway, atoB, hmgs,
and hmgr, were assembled into a synthetic operon. The
latter half of the MEV pathway consists of the remaining
three genes and IPP isomerase, which were also assembled
into a synthetic operon to construct pMBI.
Plasmid construction
Construction of the MEP pathway combinations was done
in pCDFDuet (Novagen), and all genes were cloned from
E. coli. All genes contained in frame native stop codons to
eliminate any C-terminal fusion tags from vectors. In all
cases, NcoI and NotI were used for cloning into the MCS 1
site, whereas NdeI and XhoI were used for cloning into the
MCS 2 site. These sites eliminate any N-terminal fusion
tags from the vectors. This was performed using standard
PCR protocols, restriction enzyme digest, and T4 ligation.
All constructs were verified by complete sequencing of the
insert, with inclusion of the relevant ribosome-binding sites.
Plasmid pIDI consisted of the E. coli idi gene inserted into
MCS 2. Plasmid pDXS consisted of dxs inserted into
MCS 1. Plasmid pDXR consisted of dxr inserted into MCS
2. Plasmid pDR consisted of dxs inserted into MCS 1 and
dxr inserted into MCS 2. Plasmid pIS consisted of idi
inserted into MCS 2 and dxs inserted into MCS 1. Plasmid
pIR consisted of idi inserted into MCS 1 and dxr inserted
into MCS 2. Plasmid pIRS consisted of an MCS 2 two-
gene operon of idi and dxr with a ribosome-binding site and
eight nucleotides in-between, while dxs was inserted into
MCS 1.
Construction of the pMevT/tHMGR duet vector, here
called pMTH, was performed using a pETDuet base vector
(Novagen) with a truncated copy of yeast HMGR ligated
into MCS 2 using NdeI and KpnI sites, following
incorporation of cut sites by PCR onto tHMGR using
pMEVT as template. Within MCS 1 of pETDuet, a DEST
cassette (Invitrogen) was ligated as previously noted, thus
creating pETDuetDEST. PCR of the entire MevT operon
using standard protocols was used for TOPO cloning to
create a pENTR plasmid (Invitrogen) housing the entire
operon, which was verified by complete sequencing. The
MevT operon was inserted into the DEST cassette of the
pCDFDuetDEST vector using standard LR recombination.
The pMBID plasmid was constructed in a similar
fashion as pMBIS, as described by Martin et al. (2003).
Briefly, SacI and SacII sites were incorporated by PCR at
the 5′ and 3′ ends, respectively, of a GGPP synthase from A.
grandis (Burke and Croteau 2002), enabling its insertion
into the MBI operon, which was verified by complete
sequencing.
Culture growth
All media recipes were made at pH 7 and autoclaved with
the appropriate starting ingredients. NZY media for 1 L was
made with 5 g yeast extract, 10 g casein hydrolysate, 5 g
NaCL, and 1 g MgSO4. NZYB consisted of NZY plus
phosphate buffer. TB media for 1 L was made containing
12 g yeast extract, 24 g casein hydrolysate, 4 mL glycerol,
and phosphate buffer. FL media for 1 L was comprised of
10 g yeast extract, 20 g casein hydrolysate, 5 g NaCL, 1 g
MgSO4, 20 mL glycerol, and phosphate buffer. Supple-
mentation with glycerol and phosphate buffer occurred at
the time of induction.
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All transformations were carried out using E. coli strain
C41 Overexpress (Lucigen), an optimal strain for terpene
synthase expression (Prisic and Peters 2007). Transforma-
tions consisting of three or more plasmids required 0.5 µg
plasmid DNA in 50 µL aliquots of chemically competent E.
coli C41 cells. The resulting recombinant strains were
grown under selective conditions using the appropriate
antibiotics at concentrations of 25 µg/mL for carbenicillin,
20 µg/mL for chloramphenicol, 15 µg/mL tetracycline, and
15 µg/mL spectinomycin. For all concentrations listed,
negative controls lacking resistance to one marker con-
firmed the ability of the lower antibiotic concentrations to
fully inhibit growth. Expression growths were initiated
from several colonies inoculated together into liquid media.
For all shake flasks cultures, initial growth to log phase was
carried out at 37 °C (A600 ∼0.6), with the temperature then
dropped to 16 °C, whereupon the pH was adjusted to 7.0
and phosphate buffer and glycerol, where described, were
added. Shaking was held at 200 rpm, and the cultures
induced 1 h after dropping the temperature to 16 °C by the
addition of IPTG to 1 mM. Baffled flasks were tested under
the same conditions as regular Erlenmeyer flasks.
During growth, cultures were intermittently monitored
for pH, cell density, and where applicable, product output
(as indicated in the various figures). Cell density was
monitored by absorbance of aliquots (one in ten dilutions)
at 600 nm in a Varian spectrophotometer. Culture pH was
monitored throughout growth and adjusted, if necessary, to
ensure that the culture pH remained in the 6.5 to 7.5 range,
although the cultures rarely required adjustments after the
shift to 16 °C. Supplementation with pyruvate or mevalo-
nolactone was administered via pulse feeding with 1 M
solutions at regular intervals of 12 h for the first 36 h, up to
the desired maximum concentration. Investigation of the
role of cell density on product formation (Fig. 3) was
conducted in 48 h parallel aliquots for each density, from
the time of IPTG induction, whereby the cell densities were
controlled by moving the culture in aliquots from the initial
incubation temperature of 37 to 16 °C, where it was held
for the remainder of the time course. The values recorded
Table 3 Vectors used in this study
Vector Marker Gene inserts/cassettes Copy number Parent (replicon) Reference
pMBI Tet ERG12, ERG8, MVD1, idi Low pBBR1 (Martin et al. 2003)
pMBID Tet ERG12, ERG8, MVD1,idi, GGPPS Low pMBI This study
pMevT Chlor atoB, tHMGR, HMGS Med pLac33 (ColE1) (Martin et al. 2003)
pCDF-MevT Spec DEST::atoB, tHMGR, HMGS Low/med pCDFDuet (CloDF13) This study
pET-DEST-tHMGR Amp DEST cassette, tHMGR Med pETDuet (ColE1) This study
pMTH Amp DEST::(atoB, tHMGR, HMGS), tHMGR Med pETDuet (ColE1) This study
pGG Chlor GGPPS Low pACYCDuet (P15A) (Cyr et al. 2007)
pGGAS Chlor GGPPS, AgAS Low pGG (P15A) (Cyr et al. 2007)
pGGnC Chlor GGPPS, AgAS:D621A Low pGG (P15A) (Cyr et al. 2007)
pGGeC Chlor GGPPS, AtCPS Low pGG (P15A) (Cyr et al. 2007)
pGGsC Chlor GGPPS, OsCPS4 Low pGG (P15A) (Cyr et al. 2007)
pAS Amp AgAS Med pDEST14 (ColE1) This study
pIDI Spec idi Low/med pCDFDuet (CloDF13) This study
pDXS Spec dxs Low/med pCDFDuet (CloDF13) This study
pDXR Spec dxr Low/med pCDFDuet (CloDF13) This study
pSR Spec dxs, dxr Low/med pDXR (CloDF13) This study
pIS Spec dxs, idi Low/med pIDI (CloDF13) This study
pIR Spec dxr, idi Low/med pIDI (CloDF13) This study
pIRS Spec dxs, idi, dxr Low/med pIR (CloDF13) This study
pGG-DEST Chlor GGPPS, DEST cassette Low pGG (P15A) This study
pCDFDuet-DEST Spec DEST cassette Low/med pCDFDuet (CloDF13) This study
pETDuet-DEST Amp DEST cassette Med pETDuet (ColE1) This study
pACYCDuet-DEST Chlor DEST cassette Low pACYCDuet (P15A) This study
pGGeC(An2) Chlor GGPPS, DEST cassette, An2 Low pGG-DEST (P15A) This study
pGGeC(OsCPS2) Chlor GGPPS, DEST cassette, Os31 Low pGG-DEST (P15A) This study
pGGeC(BjCPS) Chlor GGPPS, DEST cassette, BjCPS Low pGG-DEST (P15A) This study
pDEST-class I Amp DEST cassette, class I synthase Med ColE1 This study
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for the cell density are the average of the two aliquots; the
percent variance between the duplicate cell densities was
smaller than the percent variance between the determined
abietadiene yield, therefore error in abietadiene yield is
displayed. Note that the data reported in Tables 1 and 2, as
well as Figs. 2, 3, 4, 5, 7, and 8, were derived from parallel
fermentation runs (i.e., all the data reported in each of these
came from cultures grown together in the same incubator,
each in duplicate).
Bioreactor growths were conducted in a New Brunswick
BioFlo110 fermentor, set up according the manufacturer's
instructions. Under our settings, the cultures were stirred at
300 rpm, their temperature maintained at 20 °C, pH held at
7.2 (using 5 M KOH and 5 M HCL reservoirs connected to
the A and B pumps), chemically resistant tubing was used,
and air flow was maintained at 4 lpm using triple micron
filtered air. Pulse feeding supplements were introduced
through the feeding septa, and cell density and product
output monitored, as well as pH verified, by intermittent
sample removal for subsequent measurement.
Product analysis
Abietadiene analysis consisted of hexane extraction, fol-
lowed by verification and quantification by gas chroma-
tography (GC) with flame ionization detection (FID) or
mass spectrometry (MS) analyses, as described previously
(Cyr et al. 2007). Throughout the extractions, glass was
exclusively used, as plastic may result in absorption of
hydrophobic diterpenes. Preliminary work demonstrated
that extraction of entire cultures (media and cells together)
resulted in the same level of extraction efficiency as
cultures that were separated by centrifugation in glass tubes
into cell pellet and media followed by separate extraction of
the separated cell pellet and media. Mixed phase cultures or
extractions utilizing hydrophobic beads (Sepabeads SP850,
Supelco) did not result in an increase in product extraction
or production. Additionally, hexane was shown to be a
suitable organic solvent for extraction as other solvents, such
as ethyl acetate, or mixtures of solvents resulted in the same
efficiency of extraction as hexane, which has the advantage
of being more easily evaporated under nitrogen gas.
At the completion of growth, cultures were lysed by
brief sonication, and hexane was added in an equal volume
(i.e., for 50 mL cultures, 50 mL of hexane was overlayed).
The lysed cultures were then vigorously shaken multiple
times for thorough extraction and then allowed to settle
overnight at 4 °C. Additionally, sonication was verified to
not cause diterpene rearrangement or degradation. To assist
in emulsion removal in the organic phase, 2% (volumer per
volume) amount of ethanol was added to disrupt surface
tension of the emulsion and clear the organic phase. In all
cases, emulsions were agitated until they comprised less
than 20% of the total mixture volume; addition of acid will
reduce emulsions even further, till they comprise a minimal
volume as evidenced by a thin layer between phases.
Simple extraction with hexane routinely resulted in diter-
pene isolation that was >90% pure as determined by GC-
FID. In cases where alcohol derivatives emerged,
presumably caused by dephosphorylation of prenyl diphos-
phate intermediates, as identified by GC-MS, passage over
silica gel columns absorbed the oxygen containing byprod-
ucts while permitting the diterpenes to pass through,
although the mixture of abietadiene double bond isomers
also then undergoes rearrangement to the most stable abieta-
7,13-diene form (Peters et al. 2000). A known volume
aliquot of the organic overlay (10 mL in the case of 50 mL
cultures) was removed and evaporated in glass test tubes
under a stream of inert diatomic nitrogen gas. The sample
was then resuspended in 1 mL of hexane for GC analysis.
Verification of abietadiene was provided by GC-FID and
GC-MS comparison with authentic abietadiene produced by
assays with purified, recombinant AgAS reacting with
GGPP, as previously described (Wilderman and Peters
2007). Quantification was made by GC-FID peak area
comparison to cembrene, a commercially available diter-
pene hydrocarbon, as well as kaurene, a synthetic standard
of known quantity; each demonstrated identical linear
agreement of peak area in quantities ranging from 5 to
1000 ng for cembrene and 5 to 100 ng for kaurene.
Additionally, it was later found that sonication of cultures
did not improve extraction efficiency, with extraction of
unlysed (i.e., nonsonicated) culture offering the added
benefit of decreased emulsion formation. However, to
maintain consistency throughout, all measurements
reported in this manuscript were from cultures that had
been sonicated prior to extraction.
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